Itron, Inc. (NASDAQ:ITRI – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $131.2222.
Several equities analysts have issued reports on the stock. TD Cowen decreased their price objective on shares of Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Raymond James Financial assumed coverage on shares of Itron in a research note on Tuesday, April 21st. They issued an “underperform” rating for the company. Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 26th. Oppenheimer upped their target price on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a report on Thursday, April 16th. Finally, Needham & Company LLC initiated coverage on shares of Itron in a report on Friday, March 6th. They issued a “buy” rating and a $124.00 target price for the company.
View Our Latest Report on ITRI
Itron Stock Performance
Itron (NASDAQ:ITRI – Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company had revenue of $586.98 million during the quarter, compared to the consensus estimate of $572.04 million. During the same quarter in the prior year, the firm posted $1.52 earnings per share. Itron’s revenue for the quarter was down 3.3% on a year-over-year basis. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Sell-side analysts predict that Itron will post 6.01 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, SVP Laurie Ann Pulatie-Hahn sold 729 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $73,023.93. Following the completion of the sale, the senior vice president directly owned 32,950 shares of the company’s stock, valued at approximately $3,300,601.50. This represents a 2.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO David Marshall Wright sold 264 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $26,444.88. Following the completion of the sale, the chief accounting officer directly owned 9,124 shares of the company’s stock, valued at $913,951.08. The trade was a 2.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 51,162 shares of company stock valued at $5,080,646. 1.77% of the stock is owned by insiders.
Institutional Investors Weigh In On Itron
A number of institutional investors and hedge funds have recently made changes to their positions in the business. PNC Financial Services Group Inc. raised its holdings in shares of Itron by 26.3% in the first quarter. PNC Financial Services Group Inc. now owns 4,690 shares of the scientific and technical instruments company’s stock valued at $420,000 after buying an additional 977 shares during the last quarter. Summit Global Investments purchased a new position in Itron during the first quarter worth about $313,000. WCM Investment Management LLC raised its holdings in Itron by 49.5% during the first quarter. WCM Investment Management LLC now owns 87,175 shares of the scientific and technical instruments company’s stock worth $7,312,000 after purchasing an additional 28,857 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Itron by 20.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock worth $137,659,000 after purchasing an additional 265,039 shares in the last quarter. Finally, SEB Asset Management AB purchased a new position in Itron during the first quarter worth about $521,000. 96.19% of the stock is owned by hedge funds and other institutional investors.
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Featured Stories
- Five stocks we like better than Itron
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
